|
|
|
|
 |
|||||||||||||||||||
|
|
|||||||||||||||||||
|
|||||||||||||||||||
|
Past Frontiers of Science Events
Apr 22, 2008 • 1:00 PM - 5:00 PM Alan Daugherty, University of Kentucky; Colin D. Funk, Queen's University; Richard M. Lawn, CV Therapeutics; Rajendra K. Tangirala, David Geffen School of Medicine at UCLA
Sponsored by: Biochemical Pharmacology Discussion Group Organizer: Richard Ingraham, Boehringer Ingelheim Pharmaceuticals Apr 21, 2008 • 5:00 PM - 7:30 PM Speakers: Michael Doyle, University of Georgia; Robert Tauxe, CDC; Robert Buchanan, FDA; Chuck Gerba, University of Arizona; Ewen Todd, MSU Sponsored by: Emerging Infectious Diseases Discussion Group
Emerging infectious diseases are those that have newly appeared in a population or that have existed but are rapidly increasing in incidence or geographic range. This discussion group features keynote presentations by principal investigators, along with short presentations by promising graduate students and postdocs. Apr 15, 2008 • 8:30 AM - 5:00 PM Speakers: Sebastien Bouret, University of Southern California; Patrick Catalano, Case Western Reserve University; Jeremy Coplan, SUNY Downstate Medical Center; Rudolph Leibel, Columbia University; Barry Levin, UMDNJ; Tanja Kral, University of Pennsylvania; John Kral, SUNY Downstate Medical Center; Peter Nathanielsz, University of Texas Health Science Center; Andreas Plagemann, University of Medicine Berlin; Robert Waterland, Baylor College of Medicine; Robert Whitaker, Temple University Sponsored by: Diabetes and Obesity The Diabetes and Obesity discussion group explores the correlation between the growing trend of obesity and rising number of those diagnosed with diabetes. Apr 7, 2008 • 1:00 PM - 5:00 PM Speakers: Kathleen Gabrielson, Johns Hopkins University; Michael Welch, Washington University at St. Louis; Peter Choyke, NIH / National Cancer Institute; Robert Dunstan, Biogen Idec Sponsored by: Predictive Toxicology Discussion Group The current meeting focuses on imaging approaches that provide an easier, faster or more specific readout of xenobiotic response, end organ toxicity and/or off-target effects. Mar 25, 2008 • 1:00 PM - 5:00 PM Speakers: Oliver Bosch, University of Regensburg, Regensburg, Germany;
C. Sue Carter, University of Illinois at Chicago; Eric Hollander, Mt. Sinai School of Medicine; Robert H. Ring, Wyeth Research
Sponsored by: Biochemical Pharmacology Discussion Group This meeting is being held jointly with the American Chemical Society's New York Section. Mar 24, 2008 • 1:00 PM - 5:00 PM Speakers: David H. Cribbs, University of California, Irvine; Grant Krafft, Acumen Pharmaceuticals, Inc; Dave Morgan, University of South Florida; James AR Nicoll, University of Southampton, UK Sponsored by: Vaccine Science Preclinical and early clinical studies suggest that immunotherapeutic approaches targeting various forms of amyloid beta are promising for the prevention and resolution of progressive AD-like pathologies. This session will cover various immunological approaches that target amyloid beta. Mar 20, 2008 • 9:00 AM - 5:00 PM Speakers: Cheng-Yu Lee, University of Michigan; Weimin Zhong, Yale University; Sally Temple, New York Neural Stem Cell Institute, Albany Medical College; Oliver Hobert, Columbia University; Jeremy Dasen, New York University; Stephen Noctor, UC Davis; Rene Hen, Columbia University; Tracey J. Shors, Rutgers University; Fernando Nottebohm, The Rockefeller University Sponsored by: Neurodegenerative Diseases Discussion Group This symposium will explore the development of the nervous system, neural stem cell maintenance and the role of adult neurogenesis. Mar 13, 2008 • 1:00 PM - 5:00 PM Speakers: Peter Sicinski, Dana-Farber Cancer Institute, Harvard Medical School; David Glover, Cyclacel Pharmaceuticals, Inc.; Rachael Hawtin, Sunesis Pharmaceuticals, Inc.; René Medema, University Medical Center, The Netherlands; Chiang Li, Beth Israel Deaconess Medical Center, Harvard Medical School; Boston Biomedical, Inc. Sponsored by: Cancer and Signaling Discussion Group In this symposium, new discoveries in cell-cycle regulation will be presented, followed by recent clinical investigations highlighting promising new drug candidates that appear to restore checkpoint control and direct tumor cells to apoptosis. Mar 10, 2008 • 5:00 PM - 7:30 PM Speakers: Graham Ruby, Whitehead Institute for Biomedical Research, MIT; Katsutomo Okamura, Memorial Sloan Kettering Cancer Center; Michael Snyder, Yale University
Sponsored by: RNAi Discussion Group The goal of this group is to provide a forum for scientists engaged in research into the biology, biochemistry, and applications of RNAi silencing to discuss advances in this exciting new field and to promote interinstitutional and interdisciplinary dialogue. Feb 27, 2008 • 5:00 PM - 7:30 PM Speakers: Joel P. Schneider, University of Delaware; Vincent P. Conticello, Emory University; David A. Tirrell, California Institute of Technology Sponsored by: Chemical Biology Discussion Group Organizers: Jin Montclare, Polytechnic University; Isaac Carrico, Stony Brook University Feb 19, 2008 • 9:00 AM - 5:00 PM Speakers: Mary F. Dallman, University of California San Francisco; Carlos Forray, Lundbeck Research USA; Zul Merali, University of Ottawa; Alexandros Vgontzas, Penn State College of Medicine; Sonia Lupien, Douglas Institute; Frank M. LaFerla, University of California, Irvine Sponsored by: Biochemical Pharmacology Discussion Group Organizers: Irina Antonijevic, Lundbeck Research USA; David R. Riddell, Wyeth Discovery Neuroscience Feb 7, 2008 • 5:00 PM - 7:00 PM Speakers: Peter Hotez, Sabin Vaccine Institute and George Washington University; Luis de la Maza, University of California, Irvine; Albert Ko, Instituto Gonçalo Moniz, Brazil and Weill Medical College of Cornell University Sponsored by: Vaccine Science This symposium will address the scientific challenges of developing vaccine antigens for the Neglected Tropical Diseases, as well as the economic and political hurdles for technology transfer, manufacture, and global access for vaccines that target the poorest people in the developing world. Feb 7, 2008 • 5:00 PM - 7:00 PM Speakers: Peter Hotez, Sabin Vaccine Institute and George Washington University; Luis de la Maza, University of California, Irvine; Albert Ko, Instituto Gonçalo Moniz, Brazil and Weill Medical College of Cornell University Sponsored by: Emerging Infectious Diseases Discussion Group
This symposium will address the scientific challenges of developing vaccine antigens for the Neglected Tropical Diseases, as well as the economic and political hurdles for technology transfer, manufacture, and global access for vaccines that target the poorest people in the developing world. Feb 4, 2008 • 1:00 PM - 5:00 PM Speakers: John Davis, Pfizer Global Research; Barbara J. Evans, University of Houston Law Center; Carol Reed, Clinical Data, Inc.; Steve Shak, Genomic Health; Langdon Miller, PTC Therapeutics;
Sponsored by: Predictive Toxicology Discussion Group This symposium will bring together experts in pharmacogenomics, toxicogenomics, and drug discovery and development to discuss current and emerging applications of personalized medicine. Jan 24, 2008 • 5:00 PM - 7:30 PM Speakers: Denise Montell, Johns Hopkins University School of Medicine; J. Silvio Gutkind, National Institute of Dental and Craniofacial Research, NIH; Jiri Zavadil, New York University School of Medicine Sponsored by: Cancer and Signaling Discussion Group Tumor transition to a more mesenchymal-like state plays a major role in the progression of cancer, and the acquisition of a mesenchymal phenotype is correlated with poor prognosis. Jan 22, 2008 • 1:00 PM - 5:30 PM Speakers:
Ronald Quinn,
Griffith University, Brisbane, Australia;
Guy T. Carter, Wyeth Research; Ray Lam, Nereus Pharmaceuticals, Inc.; Sheo Singh, Merck Research Laboratories; Arnold Demain, Drew University.
Sponsored by: Biochemical Pharmacology Discussion Group This symposium will examine how natural products are being re-examined as potential source for new leads in the drug discovery process. Dec 13, 2007 • 4:00 PM - 7:30 PM Speakers: Roger Glass, Fogarty Institute, NIH; Debbie Saslow, American Cancer Society; Keith P. Klugman, Emory University; Christopher Plowe, University of Maryland; Rino Rappuoli, Novartis Siena Vaccine Division Sponsored by: Emerging Infectious Diseases Discussion Group
Dec 11, 2007 • 1:00 PM - 5:30 PM Speakers: Jeff Zigman, University of Texas Southwestern Medical Center; Michael Thorner, University of Virginia; Matthias Tschoep, University of Cincinnati; Sabrina Diano, Yale Unversity School of Medicine; Roy G. Smith, Baylor College of Medicine Sponsored by: Biochemical Pharmacology Discussion Group Organizers: John R. Zysk, AstraZeneca Pharmaceuticals and Brian J. Murphy, Bristol-Myers Squibb Company Dec 5, 2007 • 5:00 PM - 7:30 PM Speakers: Michael K. Racke, The Ohio State University Medical Center; Ann Marie Schmidt, Columbia University; Robert Finberg, University of Massachusetts Medical Center. Sponsored by: Neuroimmunology Discussion Group Inflammation in the brain is stimulated by multiple different pathways, this symposium will focus on the latest in our understanding of the molecular basis of CNS inflammation caused by stimulation of these systems and how this understanding may lead to the development of novel therapeutic interventions. Dec 3, 2007 - Dec 4, 2007 Sponsored by: Systems Biology Discussion Group The DREAM project is a timely effort to evaluate methods for predicting biological networks. This year's conference will include discussion of a competition to infer anonymous networks from pure data.  |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Home |
Events |
Programs |
eBriefings |
Science & the City |
Annals |
Publications |
Support |
Advertise |
About |
|
 |
RSS